683210-72-2

Upstream product

• 683210-65-3 (1S,2R,4'R,5'S)-(biphenyl-4-sulfonylamino)-[5'-(1-hydroxy-2-methanesulfonyloxyethyl)-2',2'-dimethyl[1,3]dioxolan-4'-yl]acetic acid methyl ester 
• 683210-55-1 (2R,4'S,4R,5R)-(biphenyl-4-sulfonylamino)-[2',2',2,2-tetramethyl-[4',4]bi([1,3]dioxolanyl)-5'-yl]acetic acid methyl ester 
• 683210-59-5 (1R,2R,4'R,5'S)-(biphenyl-4-sulfonylamino)-[5'-(1,2-dihydroxyethyl)-2',2'-dimethyl[1,3]dioxolan-4'-yl]acetic acid methyl ester 
• 170997-51-0 methyl 2-amino-2-deoxy-3,4;5,6-di-O-isopropylidene-D-gluconate 
• 1623-93-4 4-diphenylsulfonyl chloride 
• 683210-68-6 (3aR,4R,7R,7aR)-5-(biphenyl-4'-sulfonyl)-7-hydroxy-2,2-dimethylhexahydro[1,3]dioxolo[4,5-c]-4-carboxylic acid methyl ester 

Relevant academic research and scientific papers

Azasugar-Based MMP/ADAM Inhibitors as Antipsoriatic Agents

As a part of synthetic studies on MMP (matrix metalloproteinase)/ADAM (a disintegrin and metalloproteinase) inhibitors, we have preliminarily communicated that azasugar-based compound 1a exhibited a potential inhibitory activity on some metalloprotease-ca